ArticleCell death and differentiation2026
CD147 promotes NSCLC metastasis by inducing secretory autophagy-dependent exosome secretion via TRIM56-mediated ubiquitination and degradation of GCN2.
Article in Cell death and differentiation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Nanomaterial-driven spatiotemporal autophagy modulation: The dual-edged sword in precision cancer therapy.Acta pharmaceutica Sinica. B · 2026Review
- Multi-omics-driven precision medicine.iMeta · 2026Review
- Integrating Single-Cell, Bulk, and Spatial Transcriptomics Unveils a Novel Ribosome Biogenesis-Related Prognostic Model and DefinesInternational journal of molecular sciences · 2026Article
- Extracellular vesicles in solid tumors: from tumor ecology to engineered therapeutics.Molecular cancer · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Tumor-derived exosome secretion dynamically correlates with malignant progression, although the mechanisms by which tumor-associated antigens regulate exosome production remain unclear. Here, we found that the number of plasma exosomes increased significantly with the progression of non-small-cell lung cancer (NSCLC) patients and identified that CD147 as a crucial mediator of exosome secretion using mass spectrometry. CD147 exhibited a positive correlation with exosomes release in NSCLC patients and various cell lines and it drove the release of exosome to promote tumor metastasis in vitro and in vivo. Transcriptomic profiling of transgenic CD147 models identified differential gene expression patterns enriched in autophagy-related pathways. Intriguingly, CD147 was found to specifically enhance autophagosome and amphisome biogenesis to promote exosomes release by using transmission electron microscopy, high-sensitivity structured light microscope, RFP-GFP-LC3 adenovirus reporters and immunofluorescence, which indicated the role of CD147 in mediating non-canonical autophagy processes. Mechanistically, CD147 activated the GCN2/EIF2α/ATG12 signaling axis to drive autophagosome assembly but blocked autolysosome maturation by inhibiting VAMP8/STX17/SNAP29-dependent fusion, leading to amphisome accumulation. Proteomics identified TRIM56 as a novel E3 ligase mediating K619 ubiquitination-dependent GCN2 proteasomal degradation. Subsequently, we found that CD147 suppresses TRIM56 expression, thereby stabilizing GCN2 to activate the GCN2/EIF2α/ATG12 axis. Meanwhile, CD147-induced IP3R3-mediated calcium overload facilitated the fusion of autophagosomes with multivesicular bodies to form amphisomes, thus enhancing exosome release. Collectively, our findings reveal a novel mechanism whereby CD147 promotes crinophagy-mediated exosome secretion through dual regulation of GCN2 stability and calcium homeostasis, thereby accelerating NSCLC progression. Our work establishes a new molecular link between autophagy modulation and cancer progression.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.